INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
2.000
+0.030 (1.52%)
Sep 16, 2025, 12:30 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
INKmune and DN-TNF Product Platform
14.00K
Log In
Log In
Log In
Log In
INKmune and DN-TNF Product Platform Growth
-90.97%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
14.00K
Log In
Log In
Log In
Log In
United States Growth
-90.97%
Log In
Log In
Log In
Log In